Expression des "corticotropin releasing faktor rezeptors 2" (CRFR2) in der humanen Prostata: Ein möglicher ansatzpunkt bei der therapie der benignen prostatahyperplasie

Translated title of the contribution: Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate: A new potential target for medical therapy of benign prostatic hyperplasia

H. Tezval*, A. S. Merseburger, M. Seidler, J. Serth, M. A. Kuczyk, M. Oelke

*Corresponding author for this work
3 Citations (Scopus)

Abstract

Background. Expression of urocortin (Ucn), a 40-amino-acid neuropeptide, was demonstrated in the prostatic tissue of patients with benign prostatic hyperplasia (BPH). Ucn showed a significant role in the regulation of local inflammation, proliferation, and relaxation of smooth muscle tone in different organs through activation of corticotropin releasing factor receptor 2 (CRFR2). However, CRFR2 expression in human benign prostatic tissue remains unknown. Our study therefore aimed to investigate CRFR2 expression in prostatic tissue. Methods. CRFR2 expression was evaluated in tissue samples of human prostate (n=8) by means of reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry. Results. mRNA of CRFR2 was abundantly present in RT-PCR of prostate lysates. Immunohistochemistry revealed CRFR2 expression in the cytoplasm of basal and luminal epithelial cells as well as in cystic glands. Smooth muscle components of the stroma and vascular endothelial cells also showed extensive staining for CRFR2. Conclusions. Our study showed for the first time that human prostatic tissue expresses CRFR2. Pharmacological CRFR2 modulation might be a potential medical treatment for clinical BPH.

Translated title of the contributionExpression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate: A new potential target for medical therapy of benign prostatic hyperplasia
Original languageGerman
JournalUrologe - Ausgabe A
Volume47
Issue number9
Pages (from-to)1079-1084
Number of pages6
ISSN0340-2592
DOIs
Publication statusPublished - 09.2008

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

Fingerprint

Dive into the research topics of 'Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate: A new potential target for medical therapy of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Cite this